97594882 - IMMUNITYBIO

Information

• Trademark
• 97594882

• Source

• Serial Number

  97594882

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  September 16, 2022
  2 years ago

• Transaction Date

  August 06, 2024
  6 months ago

• Status Date

  August 05, 2024
  6 months ago

• Location Date

  August 05, 2024
  6 months ago

• First Use Anywhere Date

  January 18, 2022
  3 years ago

• First Use In Commerce Date

  July 19, 2022
  2 years ago

• Status Code

  661

• Current Location

  TMO LAW OFFICE 125 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  AVENT, TEAGUE A

• Attorney Docket Number

  302941-00002

  Attorney Name

  Michael J. McCue

  Law Office Assigned Location Code

  N70

• Owners

  • NANTCELL, INC.

Case File Statements

• GS0051: Pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; biological preparations for medical purposes, namely, vaccines for human use and animal use; low-dose chemotherapies, low dose radiation therapies, and personalized neoepitope-targeted therapies, all of the foregoing in the nature of pharmaceutical preparations for medical use for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases, and cancer; anti-cancer preparations; vaccines; biologics, namely, cell-derived preparations, cell therapies, monoclonal antibodies, cytokines, immune modulators, low-dose chemotherapy, low-dose radiation therapy, antibodies, fusion proteins, peptide and cytokine biologics, vaccines, personalized neoepitope-based therapies, cell therapies, and natural killer cell derived preparations, all of the foregoing in the nature of pharmaceutical preparations for clinical, medicinal, therapeutic, and veterinary purposes; kits for clinical, medicinal, therapeutic, and veterinary purposes comprised of clinical medical reagents, cell cultures media for laboratory use, and related printer user instructions sheets

Case File Event Statements

• 10/3/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/20/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 6/27/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/27/2023 - a year ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/27/2023 - a year ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/27/2023 - a year ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/27/2023 - a year ago

  7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 9/27/2023 - a year ago

  8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 12/20/2023 - a year ago

  9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/20/2023 - a year ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/21/2023 - a year ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/5/2024 - a year ago

  13 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/5/2024 - a year ago

  12 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/5/2024 - a year ago

  14 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/6/2024 - 9 months ago

  15 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 5/6/2024 - 9 months ago

  16 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 8/5/2024 - 6 months ago

  18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/5/2024 - 6 months ago

  19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/5/2024 - 6 months ago

  17 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA